NextGen Healthcare, Inc.
NXGN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.45 | -10.16 | 4.66 | -1.28 |
| FCF Yield | 0.55% | 1.81% | 5.81% | 8.59% |
| EV / EBITDA | 27.71 | 25.61 | 16.63 | 28.47 |
| Quality | ||||
| ROIC | -1.43% | 0.76% | 4.50% | 6.38% |
| Gross Margin | 47.64% | 50.46% | 50.54% | 50.50% |
| Cash Conversion Ratio | -16.45 | 33.09 | 10.35 | 11.42 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.46% | 3.35% | 1.71% | 0.58% |
| Free Cash Flow Growth | -74.88% | -63.72% | 19.51% | 135.33% |
| Safety | ||||
| Net Debt / EBITDA | 3.66 | -0.74 | -0.60 | 1.59 |
| Interest Coverage | 2.58 | 7.43 | 5.94 | 10.89 |
| Efficiency | ||||
| Inventory Turnover | 47.05 | 9.48 | 10.61 | 13.15 |
| Cash Conversion Cycle | 47.49 | 89.16 | 82.92 | 75.91 |